3,350
Participants
Start Date
September 22, 2006
Study Completion Date
January 30, 2007
Fluarix
adjuvanted influenza vaccine
GSK Investigational Site, Bekkestua
GSK Investigational Site, Hamar
GSK Investigational Site, Elverum
GSK Investigational Site, Paradis
GSK Investigational Site, Haugesund
GSK Investigational Site, Ghent
GSK Investigational Site, Berlin
GSK Investigational Site, Berlin
GSK Investigational Site, Poughkeepsie
GSK Investigational Site, Berlin
GSK Investigational Site, Berlin
GSK Investigational Site, Berlin
GSK Investigational Site, Carnegie
GSK Investigational Site, Pittsburgh
GSK Investigational Site, Rüdersdorf
GSK Investigational Site, Erie
GSK Investigational Site, Coral Gables
GSK Investigational Site, Clearwater
GSK Investigational Site, Cincinnati
GSK Investigational Site, Chaska
GSK Investigational Site, Haag
GSK Investigational Site, Langquaid
GSK Investigational Site, Höhenkirchen-Siegertsbrunn
GSK Investigational Site, Augsburg
GSK Investigational Site, Messkirch
GSK Investigational Site, Milford
GSK Investigational Site, Somers Point
GSK Investigational Site, Leipzig
GSK Investigational Site, Fredrikstad
GSK Investigational Site, Skien
Lead Sponsor
GlaxoSmithKline
INDUSTRY